About OPX Bio
OPX Bio is a company based in Boulder (United States) founded in 2007 was acquired by Cargill in April 2015. OPX Bio has raised $58.66 million across 6 funding rounds from investors including Cargill, DOE and US Renewables Group. OPX Bio operates in a competitive market with competitors including Amyris, Syngenta, AskBio, Ginkgo Bioworks and Antheia, among others.
- Headquarter Boulder, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of OPX Bio
OPX Bio has successfully raised a total of $58.66M across 6 strategic funding rounds. The most recent funding activity was a Series C round of $36.5 million completed in July 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in OPX Bio
OPX Bio has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Cargill, DOE and US Renewables Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Venture capital investments are managed in technology and healthcare sectors by this firm.
|
Locked | Locked | Locked | |
|
Investments are made in US expansion-stage energy and tech companies.
|
Locked | Locked | Locked |
Investor details for OPX Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by OPX Bio
Investment portfolio details for OPX Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - OPX Bio
Detailed financials for OPX Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Opx Bio Comparisons
Peer comparison for OPX Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of OPX Bio
OPX Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amyris, Syngenta, AskBio, Ginkgo Bioworks and Antheia, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of renewable products for industrial solutions
|
|
| Locked | Locked | Locked |
Crop protection solutions and hybrid seeds are provided for farming.
|
|
| Locked | Locked | Locked |
Gene and protein therapies are developed for treating various diseases.
|
|
| Locked | Locked | Locked |
Gene editing-based cultured ingredients are provided for agriculture.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| Locked | Locked | Locked |
Synthetic DNA is synthesized via a semiconductor-based platform.
|
Detailed competitors of OPX Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Opx Bio
Complete news archive for OPX Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about OPX Bio
OPX Bio was founded in 2007.
OPX Bio is headquartered in Boulder, United States. It is registered at Boulder, Colorado, United States.
OPX Bio is a funded company, having raised a total of $58.66M across 6 funding rounds to date.
OPX Biotechnologies was established in 2007 in Boulder, United States, within the bioproducts sector. Renewable feedstocks are transformed into biofuels and green chemistry products through proprietary bioengineering technology. The OPX EDGE platform is applied for optimizing microbes and bioprocesses, enabling equivalent performance with enhanced sustainability and reduced costs relative to petroleum alternatives. As of June 2016, the website has been redirected to Cargill due to acquisition.
OPX Bio has 9 investors. Key investors include Cargill, DOE, US Renewables Group, Mohr Davidow Ventures, and Braemar Energy Ventures.